Shuichi Mori

687 total citations
33 papers, 442 citations indexed

About

Shuichi Mori is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shuichi Mori has authored 33 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shuichi Mori's work include Estrogen and related hormone effects (8 papers), Ion channel regulation and function (7 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Shuichi Mori is often cited by papers focused on Estrogen and related hormone effects (8 papers), Ion channel regulation and function (7 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Shuichi Mori collaborates with scholars based in Japan, United States and France. Shuichi Mori's co-authors include Hiroyuki Kagechika, Shinya Fujii, Tomoya Hirano, Aya Tanatani, Ayumi Yamada, Hiroyuki Masuno, Eiichi Nakano, Tomoko Matsuda, Yujiro Tanaka and Mari Ishigami‐Yuasa and has published in prestigious journals such as Nature Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Shuichi Mori

33 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuichi Mori Japan 14 240 111 55 51 45 33 442
Sung-Eun Yoo South Korea 12 265 1.1× 279 2.5× 34 0.6× 38 0.7× 30 0.7× 22 664
Eric S. Underbakke United States 12 308 1.3× 73 0.7× 31 0.6× 37 0.7× 12 0.3× 20 495
Malin Lemurell Sweden 12 402 1.7× 184 1.7× 24 0.4× 10 0.2× 46 1.0× 15 587
Herbert Birnböck Germany 8 71 0.3× 80 0.7× 45 0.8× 25 0.5× 24 0.5× 12 238
W.C. Eckelman United States 12 174 0.7× 58 0.5× 40 0.7× 26 0.5× 193 4.3× 24 429
Michael Reilly United States 16 345 1.4× 243 2.2× 13 0.2× 20 0.4× 30 0.7× 25 763
Felix Major Germany 12 297 1.2× 171 1.5× 10 0.2× 50 1.0× 22 0.5× 15 389
V. F. Pozdnev Russia 10 229 1.0× 115 1.0× 9 0.2× 61 1.2× 23 0.5× 39 360
Scott A. Long United States 9 212 0.9× 189 1.7× 11 0.2× 14 0.3× 9 0.2× 13 429
Simeon M. Wrenn United States 9 155 0.6× 112 1.0× 8 0.1× 29 0.6× 24 0.5× 12 405

Countries citing papers authored by Shuichi Mori

Since Specialization
Citations

This map shows the geographic impact of Shuichi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Mori more than expected).

Fields of papers citing papers by Shuichi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Mori. The network helps show where Shuichi Mori may publish in the future.

Co-authorship network of co-authors of Shuichi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Shuichi Mori. A scholar is included among the top collaborators of Shuichi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuichi Mori. Shuichi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishida, Ryosuke, Nagomi Kurebayashi, Xi Zeng, et al.. (2023). A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European Journal of Medicinal Chemistry. 262. 115910–115910. 3 indexed citations
2.
Oyama, Kotaro, Fuyu Kobirumaki-Shimozawa, Takashi Murayama, et al.. (2022). Mice with R2509C-RYR1 mutation exhibit dysfunctional Ca2+ dynamics in primary skeletal myocytes. The Journal of General Physiology. 154(11). 3 indexed citations
3.
Ishida, Ryosuke, et al.. (2022). Development of a water-soluble ryanodine receptor 1 inhibitor. Bioorganic & Medicinal Chemistry. 74. 117027–117027. 4 indexed citations
4.
Murayama, Takashi, Nagomi Kurebayashi, Takuro Numaga‐Tomita, et al.. (2022). A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery. The Journal of General Physiology. 154(12). 4 indexed citations
5.
Mori, Shuichi, Mari Ishigami‐Yuasa, Takashi Murayama, et al.. (2019). Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay. European Journal of Medicinal Chemistry. 179. 837–848. 17 indexed citations
6.
Nishiyama, Yuko, Shuichi Mori, Makoto Makishima, et al.. (2018). Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton. ACS Medicinal Chemistry Letters. 9(7). 641–645. 19 indexed citations
7.
Ando, Fumiaki, Shuichi Mori, Naofumi Yui, et al.. (2018). AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus. Nature Communications. 9(1). 1411–1411. 34 indexed citations
8.
Hirano, Tomoya, Shuichi Mori, & Hiroyuki Kagechika. (2018). Recent Advances in Chemical Tools for the Regulation and Study of Protein Lysine Methyltransferases. The Chemical Record. 18(12). 1745–1759. 2 indexed citations
9.
Fujii, Shinya, Shuichi Mori, Hiroyuki Kagechika, Marco Antonio Mendoza-Parra, & Hinrich Gronemeyer. (2018). Development of biotin-retinoid conjugates as chemical probes for analysis of retinoid function. Bioorganic & Medicinal Chemistry Letters. 28(14). 2442–2445. 1 indexed citations
10.
Murayama, Takashi, Nagomi Kurebayashi, Mari Ishigami‐Yuasa, et al.. (2018). Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels. Molecular Pharmacology. 94(1). 722–730. 42 indexed citations
11.
Mori, Shuichi, et al.. (2017). Selective Reagent for Detection of N‐ε‐Monomethylation of a Peptide Lysine Residue through SNAr Reaction. European Journal of Organic Chemistry. 2017(25). 3606–3611. 1 indexed citations
12.
Mori, Shuichi, et al.. (2017). Modulating Biocatalytic Activity toward Sterically Bulky Substrates in CO2-Expanded Biobased Liquids by Tuning the Physicochemical Properties. ACS Sustainable Chemistry & Engineering. 5(11). 11051–11059. 19 indexed citations
13.
Hirano, Tomoya, et al.. (2016). Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure–activity relationships and fluorescence properties. Bioorganic & Medicinal Chemistry. 24(21). 5602–5610. 7 indexed citations
14.
Yura, Kei, Shinya Fujii, Mari Ishigami‐Yuasa, et al.. (2015). Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists. European Journal of Medicinal Chemistry. 102. 310–319. 22 indexed citations
15.
Fujii, Shinya, Ayumi Yamada, Eiichi Nakano, et al.. (2014). Design and synthesis of nonsteroidal progesterone receptor antagonists based on C,C′-diphenylcarborane scaffold as a hydrophobic pharmacophore. European Journal of Medicinal Chemistry. 84. 264–277. 28 indexed citations
16.
Fujii, Shinya, et al.. (2014). Development of p-carborane-based nonsteroidal progesterone receptor antagonists. Bioorganic & Medicinal Chemistry. 22(19). 5329–5337. 15 indexed citations
17.
Mori, Shuichi, et al.. (2014). Development of 1,3-diphenyladamantane derivatives as nonsteroidal progesterone receptor antagonists. Bioorganic & Medicinal Chemistry. 23(4). 803–809. 7 indexed citations
18.
Hirano, Tomoya, Shuichi Mori, Shinya Fujii, et al.. (2011). 6-Arylcoumarins as Novel Nonsteroidal Type Progesterone Antagonists: An Example with Receptor-Binding-Dependent Fluorescence. Journal of Medicinal Chemistry. 54(20). 7055–7065. 29 indexed citations
19.
Mori, Shuichi, et al.. (2010). Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9. Bioorganic & Medicinal Chemistry. 18(23). 8158–8166. 50 indexed citations
20.
Yanagihara, Makoto & Shuichi Mori. (1982). [Histogenesis of macular amyloidosis].. PubMed. 92(8). 851–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung-Eun Yoo Breakdown of academic impact, for papers by Eric S. Underbakke Breakdown of academic impact, for papers by Malin Lemurell Breakdown of academic impact, for papers by Herbert Birnböck Breakdown of academic impact, for papers by W.C. Eckelman Breakdown of academic impact, for papers by Michael Reilly Breakdown of academic impact, for papers by Felix Major Breakdown of academic impact, for papers by V. F. Pozdnev Breakdown of academic impact, for papers by Scott A. Long Breakdown of academic impact, for papers by Simeon M. Wrenn
Rankless by CCL
2026